Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)
CUSIP: 86366E106
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 213,001,347
- Total 13F shares
- 2,430
- Share change
- -6,740
- Total reported value
- $118,960
- Price per share
- $48.20
- Number of holders
- 4
- Value change
- -$335,068
- Number of buys
- 2
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 86366E106:
Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
3/4/5
13F
|
Other*, 10%+ Owner · Company |
15%
|
31,112,634
|
$2,163,883,695 | +$776,609,280 | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
10%
|
21,365,952
|
$1,481,942,431 | +$50,941,729 | 31 Dec 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
6%
|
12,335,346
|
$855,579,599 | -$21,646,354 | 31 Dec 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
4.9%
|
10,437,066
|
$723,914,898 | +$57,243,848 | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13F
13D/G
|
Company |
9.4%
from 13D/G
|
6,555,555
|
$455,938,850 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
5,090,148
|
$354,005,522 | — | 31 Dec 2025 | |
| BVF INC/IL |
13F
|
Company |
1.6%
|
3,479,022
|
$241,965,980 | — | 31 Dec 2025 | |
| Raymond C. Stevens |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
3,284,233
mixed-class rows
|
$217,700,989 | — | 19 Mar 2026 | |
| Jun Yoon |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
3,088,080
mixed-class rows
|
$216,491,068 | — | 19 Mar 2026 | |
| Capital Research Global Investors |
13D/G
|
— |
3.8%
|
6,492,435
|
$168,218,991 | $0 | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
2,087,834
|
$145,208,903 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.78%
|
1,671,138
|
$116,228,000 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.77%
|
1,642,444
|
$114,231,980 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.67%
|
1,432,529
|
$99,632,392 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.6%
|
1,284,210
|
$89,316,805 | — | 31 Dec 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.55%
|
1,175,000
|
$81,721,250 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.55%
|
1,161,803
|
$80,803,399 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.51%
|
1,078,698
|
$75,023,446 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.43%
|
920,857
|
$64,045,604 | — | 31 Dec 2025 | |
| Capitolis Liquid Global Markets LLC |
13F
|
Company |
0.41%
|
878,300
|
$61,085,765 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.41%
|
870,582
|
$60,548,961 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
848,851
|
$59,037,587 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
841,162
|
$58,502,817 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.36%
|
772,518
|
$53,728,627 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.36%
|
767,993
|
$53,413,913 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
748,236
|
$52,039,814 | — | 31 Dec 2025 | |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC |
13F
|
Company |
0.33%
|
700,000
|
$48,685,000 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.28%
|
600,000
|
$41,730,000 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.24%
|
506,959
|
$35,259,464 | — | 31 Dec 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.22%
|
467,800
|
$32,535,490 | — | 31 Dec 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
454,000
|
$31,575,700 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.2%
|
430,082
|
$29,912,204 | — | 31 Dec 2025 | |
| HSG Holding Ltd |
13F
|
Company |
0.12%
|
266,062
|
$24,443,116 | — | 31 Dec 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.16%
|
351,073
|
$24,417,127 | — | 31 Dec 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.16%
|
334,380
|
$23,256,129 | — | 31 Dec 2025 | |
| Crespo Blas Coll |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
376,019
mixed-class rows
|
$20,585,311 | — | 19 Mar 2026 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.13%
|
285,518
|
$19,857,777 | — | 31 Dec 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.13%
|
271,213
|
$18,862,864 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.12%
|
265,400
|
$18,458,570 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.12%
|
264,869
|
$18,421,639 | — | 31 Dec 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.12%
|
252,901
|
$17,589,265 | — | 31 Dec 2025 | |
| Capricorn Fund Managers Ltd |
13F
|
Company |
0.12%
|
252,600
|
$17,568,330 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
250,000
|
$17,387,500 | — | 31 Dec 2025 | |
| Ramy Farid |
3/4/5
|
Director |
—
mixed-class rows
|
3,535,495
mixed-class rows
|
$17,176,500 | — | 07 Feb 2023 | |
| Xichen Lin |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
282,663
mixed-class rows
|
$16,762,161 | — | 19 Mar 2026 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.11%
|
225,000
|
$15,648,750 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
224,332
|
$15,602,290 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
216,199
|
$15,036,640 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
202,477
|
$14,082,276 | — | 31 Dec 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.09%
|
201,500
|
$14,014,325 | — | 31 Dec 2025 |
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q1 2026
As of 31 Mar 2026,
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,430 shares.
The largest 5 holders included
BANQUE PICTET & CIE SA, GAMMA Investing LLC, Farther Finance Advisors, LLC, WOLFF WIESE MAGANA LLC, and SIGNATUREFD, LLC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
197
Q1 2026 holders
4
Holder diff
-193
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.